Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2016 Q2- Text added to 2016 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Academy, anatomic, arm, arthropathy, BCVA, Cabilly, CAPELLA, CRL, de, Dermatology, dismissal, driven, Dupixent, EADV, ESC, expert, fewer, France, gemcabene, Gemphire, grande, hazard, ingredient, intangible, intravenously, irritation, judgement, Le, ONYX, overwhelming, palivizumab, pJIA, proceeding, provisional, resolution, resolve, resolved, routine, RUBY, simultaneously, stipulation, stopped, subretinal, Trait, Tribunal, unplanned, Venereology, vi
Removed:
choose, criterion, desire, exemption, expiring, inventoried, launching, prostate, repurchased, survival, tentative, VENICE
Valuein 2016 Q2 filing- Value in 2016 Q3 filing
Original filings
Filing view